Skip to main content

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in AKBA — Akebia Therapeutics, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in AKBA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,801,652
-$709,468 QoQ
Shares Held
2,015,577
-7.6% QoQ
Ownership
0.727%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,626,421,306 across 43 Drug Manufacturers - Specialty & Generic names. AKBA ranks #31 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AKBA

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,801,652 2,015,577
2025-12-31 $3,511,120 2,180,820
2025-09-30 $5,924,867 2,170,281
2025-06-30 $2,726,414 749,015
2025-03-31 $1,195,994 622,914
2024-12-31 $1,114,749 586,710
2024-09-30 $750,640 568,667
2024-06-30 $582,393 570,974
2024-03-31 $146,041 79,804
2023-12-31 $98,956 79,804
2023-09-30 $90,976 79,804
2023-06-30 $73,020 79,804
2023-03-31 $44,690 79,804
2022-12-31 $76,377 132,370
2022-09-30 $41,828 132,370
2022-03-31 $342,467 476,974
2021-12-31 $1,003,345 443,958
2021-09-30 $1,278,599 443,958
2021-06-30 $4,177,372 1,102,209
2021-03-31 $3,435,551 1,014,934
2020-12-31 $2,676,825 956,009
2020-09-30 $2,365,363 942,376
2020-06-30 $14,217,227 1,046,924
2020-03-31 $5,628,998 742,612